Baltimore biotech company raises $32.5 million to continue pursuing cancer immunotherapy treatment

Source: Baltimore biotech company raises $32.5 million to continue pursuing cancer immunotherapy treatment

Unfortunately, our website is currently unavailable in most European countries. We are engaged on the issue and committed to looking at options that support our full range of digital offerings to the EU market. We continue to identify technical compliance solutions that will provide all readers with our award-winning journalism.

Published at Mon, 18 Jun 2018 23:06:15 +0000